Valproate Treatment in an ALS Patient Carrying a c.194G>A Spastin Mutation and SMN2 Homozygous Deletion.
about
Valproate Treatment in an ALS Patient Carrying a c.194G>A Spastin Mutation and SMN2 Homozygous Deletion.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Valproate Treatment in an ALS ...... and SMN2 Homozygous Deletion.
@en
Valproate Treatment in an ALS ...... and SMN2 Homozygous Deletion.
@nl
type
label
Valproate Treatment in an ALS ...... and SMN2 Homozygous Deletion.
@en
Valproate Treatment in an ALS ...... and SMN2 Homozygous Deletion.
@nl
prefLabel
Valproate Treatment in an ALS ...... and SMN2 Homozygous Deletion.
@en
Valproate Treatment in an ALS ...... and SMN2 Homozygous Deletion.
@nl
P2093
P2860
P50
P356
P1476
Valproate Treatment in an ALS ...... n and SMN2 Homozygous Deletion
@en
P2093
Antonella Fogli
Massimo Corbo
Paolo Simi
Silvana Penco
Virginia Rodriguez-Menendez
P2860
P304
P356
10.1155/2014/216094
P577
2014-07-17T00:00:00Z